BAY1002670

DRUG2 trials

Sponsors

Bayer

Conditions

Leiomyoma

Phase 1

Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670

CompletedNCT01816815

Start: 2011-11-30End: 2013-01-31Updated: 2014-04-21

Phase 2

Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap

CompletedNCT02131662

Start: 2014-05-15End: 2016-05-04Updated: 2017-12-08

Related Papers

Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study.

2018-12-0724 citations

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.

2016-06-1031 citations